|
G |
Ifng |
interferon gamma |
disease_progression |
ISO |
protein:increased expression:T cell: |
RGD |
PMID:11063842 |
RGD:8157598 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Nefl |
neurofilament light chain |
disease_progression |
ISO |
protein:increased expresssion:serum (human) |
RGD |
PMID:31383792 |
RGD:127284875 |
NCBI chrNW_004936757:1,642,122...1,646,499
|
|
|
G |
Mag |
myelin associated glycoprotein |
|
ISO |
protein:decreased expression:optic nerve |
RGD |
PMID:9820787 |
RGD:9685300 |
NCBI chrNW_004936570:989,743...1,004,820
|
|
G |
Zc3h12a |
zinc finger CCCH-type containing 12A |
disease_progression |
ISO |
|
RGD |
PMID:26320658 |
RGD:11534569 |
NCBI chrNW_004936474:19,714,145...19,722,512
|
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
|
RGD |
PMID:20680636 |
RGD:5148026 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
G |
Edar |
ectodysplasin A receptor |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:10431241 PMID:18231121 PMID:20236127 PMID:20979233 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936829:429,667...458,943
|
|
G |
Fanci |
FA complementation group I |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:15477547 PMID:16177225 PMID:17088268 PMID:17426723 PMID:17438011 PMID:17950645 PMID:17980715 PMID:18414213 PMID:18991199 PMID:19010300 PMID:20691285 PMID:21038416 PMID:21228398 PMID:21880868 PMID:22189570 PMID:23524600 PMID:23783014 PMID:24033266 PMID:24086434 PMID:25462018 PMID:25741868 PMID:26104464 PMID:26467025 PMID:27987238 PMID:28492532 More...
|
|
NCBI chrNW_004936483:15,096,215...15,179,856
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
susceptibility |
ISO |
ClinVar Annotator: match by term: Mitochondrial DNA depletion syndrome 4a | ClinVar Annotator: match by term: Neuronal degeneration of childhood with liver disease, progressive | ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy DNA:missense mutation:cds:p.P1073L (3218C>T) (human) |
OMIM ClinVar RGD |
PMID:632821 PMID:1539879 PMID:1582434 PMID:1858914 PMID:2067633 PMID:2392416 PMID:2725645 PMID:7847370 PMID:9500334 PMID:9536098 PMID:11301032 PMID:11431686 PMID:11555352 PMID:11571332 PMID:11897778 PMID:12073019 PMID:12210792 PMID:12297582 PMID:12565911 PMID:12707443 PMID:12825077 PMID:12872260 PMID:12975295 PMID:14467368 PMID:14557557 PMID:14635118 PMID:14694057 PMID:14745080 PMID:15122711 PMID:15181170 PMID:15258572 PMID:15349879 PMID:15351195 PMID:15477547 PMID:15534189 PMID:15689359 PMID:15800909 PMID:15824347 PMID:15913923 PMID:15917273 PMID:15929042 PMID:16024923 PMID:16080118 PMID:16130100 PMID:16177225 PMID:16199547 PMID:16368709 PMID:16401742 PMID:16545482 PMID:16595552 PMID:16621917 PMID:16634032 PMID:16638794 PMID:16639411 PMID:16715201 PMID:16857757 PMID:16919951 PMID:16929381 PMID:16940310 PMID:16943369 PMID:16957900 PMID:17067213 PMID:17088268 PMID:17280874 PMID:17310215 PMID:17418573 PMID:17426723 PMID:17436221 PMID:17438011 PMID:17452231 PMID:17502560 PMID:17538929 PMID:17576681 PMID:17725985 PMID:17846414 PMID:17894835 PMID:17950645 PMID:17980715 PMID:18156159 PMID:18195149 PMID:18195151 PMID:18294203 PMID:18321754 PMID:18414213 PMID:18446447 PMID:18487244 PMID:18500570 PMID:18546343 PMID:18546365 PMID:18585914 PMID:18716558 PMID:18783964 PMID:18828154 PMID:18991199 PMID:19010300 PMID:19103152 PMID:19125351 PMID:19189930 PMID:19195941 PMID:19251978 PMID:19275594 PMID:19307547 PMID:19344718 PMID:19364868 PMID:19478085 PMID:19501198 PMID:19538466 PMID:19566497 PMID:19578034 PMID:19629138 PMID:19752458 PMID:19762913 PMID:19766516 PMID:19813183 PMID:19815814 PMID:19837034 PMID:19862739 PMID:19887119 PMID:20138553 PMID:20142534 PMID:20153822 PMID:20176107 PMID:20185557 PMID:20227526 PMID:20301791 PMID:20385918 PMID:20400524 PMID:20434700 PMID:20438629 PMID:20513108 PMID:20513922 PMID:20576279 PMID:20601675 PMID:20691285 PMID:20701905 PMID:20803511 PMID:20818383 PMID:20837861 PMID:20837862 PMID:20843780 PMID:20883824 PMID:20981092 PMID:21038416 PMID:21138766 PMID:21228000 PMID:21228398 PMID:21235791 PMID:21236670 PMID:21259344 PMID:21276947 PMID:21282586 PMID:21301859 PMID:21305355 PMID:21357833 PMID:21447491 PMID:21455106 PMID:21515089 PMID:21550804 PMID:21647632 PMID:21654874 PMID:21670405 PMID:21686371 PMID:21696159 PMID:21704543 PMID:21824913 PMID:21856450 PMID:21880868 PMID:21953457 PMID:21956653 PMID:21993618 PMID:22000311 PMID:22006280 PMID:22114710 PMID:22166854 PMID:22189570 PMID:22237560 PMID:22334187 PMID:22342071 PMID:22357363 PMID:22377773 PMID:22470557 PMID:22494076 PMID:22537151 PMID:22552686 PMID:22616202 PMID:22647225 PMID:22711370 PMID:22727047 PMID:22778364 PMID:22863191 PMID:22931735 PMID:22933815 PMID:22987704 PMID:22995991 PMID:23066759 PMID:23077218 PMID:23084792 PMID:23208208 PMID:23212759 PMID:23248042 PMID:23250882 PMID:23251356 PMID:23299917 PMID:23324391 PMID:23419467 PMID:23426270 PMID:23430834 PMID:23446635 PMID:23446645 PMID:23448099 PMID:23524600 PMID:23545419 PMID:23665194 PMID:23719791 PMID:23783014 PMID:23804100 PMID:23808377 PMID:23811324 PMID:23836942 PMID:23873972 PMID:23921535 PMID:24033266 PMID:24086434 PMID:24091540 PMID:24099403 PMID:24122062 PMID:24194468 PMID:24259288 PMID:24265579 PMID:24272679 PMID:24288107 PMID:24331360 PMID:24398692 PMID:24508722 PMID:24642831 PMID:24725338 PMID:24841123 PMID:25025039 PMID:25065347 PMID:25118206 PMID:25193669 PMID:25203713 PMID:25281868 PMID:25286830 PMID:25340760 PMID:25356970 PMID:25412673 PMID:25429852 PMID:25462018 PMID:25466440 PMID:25488682 PMID:25497598 PMID:25525159 PMID:25585994 PMID:25660390 PMID:25713120 PMID:25741868 PMID:25742477 PMID:25771874 PMID:25850945 PMID:25914719 PMID:25940035 PMID:26050231 PMID:26077851 PMID:26095671 PMID:26104464 PMID:26169155 PMID:26224072 PMID:26337858 PMID:26357557 PMID:26467025 PMID:26468652 PMID:26554610 PMID:26557169 PMID:26607151 PMID:26735972 PMID:26742794 PMID:26755490 PMID:26942291 PMID:26942292 PMID:26968897 PMID:27016405 PMID:27119776 PMID:27185166 PMID:27271921 PMID:27290639 PMID:27345795 PMID:27381400 PMID:27422324 PMID:27450679 PMID:27538604 PMID:27538665 PMID:27822509 PMID:27826120 PMID:27838477 PMID:27843123 PMID:27987238 PMID:28128857 PMID:28130605 PMID:28154168 PMID:28206745 PMID:28337550 PMID:28430993 PMID:28444220 PMID:28471437 PMID:28480171 PMID:28492532 PMID:28634151 PMID:28771251 PMID:28776642 PMID:28812649 PMID:28815208 PMID:28837072 PMID:28865037 PMID:28901595 PMID:28958595 PMID:29029963 PMID:29190809 PMID:29272804 PMID:29302508 PMID:29341116 PMID:29358615 PMID:29423831 PMID:29431110 PMID:29474836 PMID:29482223 PMID:29574624 PMID:29588995 PMID:29655203 PMID:29712893 PMID:29920680 PMID:29950568 PMID:29992832 PMID:30021052 PMID:30167885 PMID:30255931 PMID:30290626 PMID:30306720 PMID:30369941 PMID:30373890 PMID:30404819 PMID:30423451 PMID:30487145 PMID:30609409 PMID:30637288 PMID:30818899 PMID:30838265 PMID:30843307 PMID:30860128 PMID:30936349 PMID:30951992 PMID:31147703 PMID:31164858 PMID:31475037 PMID:31571979 PMID:31589614 PMID:31613174 PMID:31645654 PMID:31655921 PMID:31658717 PMID:31665838 PMID:31669236 PMID:31980526 PMID:31996268 PMID:32019516 PMID:32234506 PMID:32347949 PMID:32348839 PMID:32502631 PMID:32600829 PMID:32703289 PMID:33258288 PMID:33469851 PMID:33473333 PMID:33486010 PMID:33726816 PMID:34008892 PMID:34194468 PMID:34782754 PMID:35307828 More...
|
RGD:15039298 |
NCBI chrNW_004936483:15,178,947...15,196,277
|
|
G |
Ranbp2 |
RAN binding protein 2 |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:10431241 PMID:18231121 PMID:20236127 PMID:20979233 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004936829:261,017...333,910
|
|
G |
Rlbp1 |
retinaldehyde binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: Progressive sclerosing poliodystrophy |
ClinVar |
PMID:2392416 PMID:11301032 PMID:21447491 PMID:25429852 PMID:28492532 |
|
NCBI chrNW_004936483:15,086,485...15,097,980
|
|
|
G |
Nefh |
neurofilament heavy chain |
|
ISO |
protein:decreased expression:spinal cord: |
RGD |
PMID:12742652 |
RGD:27226817 |
NCBI chrNW_004936657:3,443,406...3,453,096
|
|
G |
Plp1 |
proteolipid protein 1 |
|
ISO |
human sequence peptide in a mouse model; associated with Herpesviridae infections |
RGD |
PMID:12811845 |
RGD:30296670 |
NCBI chrNW_004936499:10,534,953...10,553,411
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
|
RGD |
PMID:17983428 |
RGD:13208507 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
ISO |
|
RGD |
PMID:15878627 |
RGD:1559178 |
NCBI chrNW_004936532:5,864,851...5,904,005
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
|
RGD |
PMID:9670863 |
RGD:2325244 |
NCBI chrNW_004936486:19,389,925...19,403,577
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
protein:altered expression:spinal cord (rat) |
RGD |
PMID:19246105 |
RGD:2313022 |
NCBI chrNW_004936727:1,907,493...1,909,350
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
|
ISO |
mRNA,protein:increased expression:spinal cord |
RGD |
PMID:20155814 |
RGD:14348972 |
NCBI chrNW_004936489:4,237,466...4,258,408
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:15328042 |
RGD:5509618 |
NCBI chrNW_004936677:3,232,183...3,241,307
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
severity |
ISO |
|
RGD |
PMID:28119027 |
RGD:14392778 |
NCBI chrNW_004936512:5,157,076...5,160,251
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
protein:increased expression:brain, astrocyte, macrophage |
RGD |
PMID:9472682 |
RGD:2306942 |
NCBI chrNW_004936503:9,124,314...9,142,372
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
|
RGD |
PMID:28578430 |
RGD:13703134 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Aqp4 |
aquaporin 4 |
disease_progression severity |
ISO |
|
RGD |
PMID:19660138 PMID:21056916 PMID:21157915 PMID:23707078 |
RGD:5148015 RGD:5490116 RGD:5490117 RGD:8696030 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
G |
B2m |
beta-2-microglobulin |
|
ISO |
|
RGD |
PMID:15837577 |
RGD:6482690 |
NCBI chrNW_004936471:7,646,504...7,655,656
|
|
G |
B4galt6 |
beta-1,4-galactosyltransferase 6 |
|
ISO |
mRNA:increased expression:astrocyte |
RGD |
PMID:25216636 |
RGD:14390079 |
NCBI chrNW_004936682:1,535,617...1,590,723
|
|
G |
Bdnf |
brain derived neurotrophic factor |
|
ISO |
|
RGD |
PMID:23212569 |
RGD:10059360 |
NCBI chrNW_004936540:5,530,081...5,582,765
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:22320401 |
RGD:7175513 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
C6 |
complement C6 |
severity |
ISO |
|
RGD |
PMID:11970970 |
RGD:625607 |
NCBI chrNW_004936518:1,471,116...1,532,733
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
|
ISO |
|
RGD |
PMID:11353727 |
RGD:1580151 |
NCBI chrNW_004936669:133,488...308,623
|
|
G |
Calca |
calcitonin related polypeptide alpha |
no_association |
ISO |
|
RGD |
PMID:19563774 |
RGD:5684360 |
NCBI chrNW_004936528:3,800,801...3,806,000
|
|
G |
Casp3 |
caspase 3 |
|
ISO |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chrNW_004936726:554,627...596,334
|
|
G |
Casp9 |
caspase 9 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Cav3 |
caveolin 3 |
onset |
ISO |
Protein:increased expression:spinal cord, astrocyte |
RGD |
PMID:15925413 |
RGD:1582168 |
NCBI chrNW_004936602:4,264,896...4,278,160
|
|
G |
Cblb |
Cbl proto-oncogene B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20453840 |
|
NCBI chrNW_004936701:1,157,790...1,353,375
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
mRNA:decreased expression:lymph node |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chrNW_004936538:781,687...784,199
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased expression:brain (mouse) mRNA:increased expression:spinal cord |
RGD |
PMID:15833367 PMID:17666800 |
RGD:2307114 RGD:4890027 |
NCBI chrNW_004936490:253,279...259,947
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15034073 |
RGD:6893394 |
NCBI chrNW_004936596:223,660...224,739
|
|
G |
Cd28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:16061730 |
RGD:2307203 |
NCBI chrNW_004936631:335,411...363,407
|
|
G |
Cd4 |
CD4 molecule |
treatment |
ISO |
protein:decreased expression:T lymphocyte: |
RGD |
PMID:3097071 PMID:9138014 |
RGD:10058963 RGD:10058968 |
NCBI chrNW_004936709:997,776...1,022,791
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chrNW_004936536:6,462,080...6,483,450
|
|
G |
Cd86 |
CD86 molecule |
resistance disease_progression |
ISO |
protein:increased expression:spinal cord, blood vessel (rat) |
RGD |
PMID:10477557 PMID:20451260 |
RGD:4892207 RGD:4892227 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Ciita |
class II major histocompatibility complex transactivator |
|
ISO |
|
RGD |
PMID:15821736 |
RGD:1358146 |
NCBI chrNW_004936530:9,033,510...9,073,341
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
|
RGD |
PMID:7541143 PMID:10650887 PMID:21107918 |
RGD:6483335 RGD:6483351 RGD:6483353 |
NCBI chrNW_004936490:16,834,570...16,841,734
|
|
G |
Comt |
catechol-O-methyltransferase |
treatment |
ISO |
|
RGD |
PMID:25242632 |
RGD:13450949 |
NCBI chrNW_004936619:3,847,059...3,883,866
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
ISO |
|
RGD |
PMID:22768796 |
RGD:7243111 |
NCBI chrNW_004936857:577,067...609,855
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:20162860 PMID:21679768 |
RGD:5686852 RGD:5686863 |
NCBI chrNW_004936471:34,438,676...34,475,005
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chrNW_004936631:484,356...489,643
|
|
G |
Ctsc |
cathepsin C |
|
ISO |
|
RGD |
PMID:843913 |
RGD:1599653 |
NCBI chrNW_004936736:1,201,343...1,240,311
|
|
G |
Ctss |
cathepsin S |
|
ISO |
|
RGD |
PMID:21439785 |
RGD:5686915 |
NCBI chrNW_004936580:963,176...991,732
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:16053521 |
RGD:4891973 |
NCBI chrNW_004936475:9,443,851...9,454,715
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:16053521 PMID:24706865 |
RGD:4891973 RGD:9491767 |
NCBI chrNW_004936473:28,508,726...28,535,640
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:21038468 |
RGD:5135506 |
NCBI chrNW_004936762:66,636...69,694
|
|
G |
Dab2 |
DAB adaptor protein 2 |
disease_progression |
ISO |
|
RGD |
PMID:21890121 |
RGD:7243155 |
NCBI chrNW_004936518:2,915,819...2,936,474
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:24676147 |
RGD:150520045 |
NCBI chrNW_004936604:4,504,519...4,511,897
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:17947672 |
RGD:6482235 |
NCBI chrNW_004937098:212,704...220,589
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
|
ISO |
|
RGD |
PMID:15306813 |
RGD:7775013 |
NCBI chrNW_004936650:679,650...718,867
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18382691 |
|
NCBI chrNW_004936543:742,722...745,332
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chrNW_004936541:4,613,197...4,705,911
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:21182085 PMID:21565615 |
RGD:5508732 RGD:5508735 |
NCBI chrNW_004936495:7,956,168...8,018,356
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:10944459 |
RGD:12903984 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Flt1 |
fms related receptor tyrosine kinase 1 |
treatment |
ISO |
|
RGD |
PMID:18721816 |
RGD:10402153 |
NCBI chrNW_004936472:23,442,946...23,617,523
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27742544 |
|
NCBI chrNW_004936564:4,788,036...4,907,600
|
|
G |
Ghrh |
growth hormone releasing hormone |
resistance |
ISO |
|
RGD |
PMID:21846799 |
RGD:5687168 |
NCBI chrNW_004936561:3,946,256...3,954,472
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
treatment |
ISO |
|
RGD |
PMID:19620309 |
RGD:12905041 |
NCBI chrNW_004936602:3,037,862...3,044,863
|
|
G |
Gjc2 |
gap junction protein gamma 2 |
|
ISO |
protein:decreased expression:white matter of spinal cord, gap junction (mouse) |
RGD |
PMID:22461072 |
RGD:13208593 |
NCBI chrNW_004936864:67,608...71,543
|
|
G |
Gli1 |
GLI family zinc finger 1 |
|
ISO |
|
RGD |
PMID:18991353 |
RGD:12801440 |
NCBI chrNW_004936646:1,622,308...1,629,787
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
mRNA, protein:decreased expression:spinal cord |
RGD |
PMID:9145307 |
RGD:6484657 |
NCBI chrNW_004936601:5,415,857...5,435,964
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
ISO |
mRNA:increased expression:spinal cord: |
RGD |
PMID:11823861 PMID:15913792 |
RGD:9686086 RGD:9686113 |
NCBI chrNW_004936515:6,001,324...6,015,407
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:14691063 PMID:17085013 |
RGD:5508469 RGD:5508476 |
NCBI chrNW_004936549:1,378,536...1,400,501
|
|
G |
Ifng |
interferon gamma |
treatment disease_progression |
ISO |
|
RGD |
PMID:15661899 PMID:22896638 |
RGD:10755692 RGD:7987912 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Igf1 |
insulin like growth factor 1 |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:7541143 |
RGD:6483353 |
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:23872438 |
RGD:7364993 |
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:12620647 |
RGD:2316323 |
NCBI chrNW_004936542:3,099,484...3,113,159
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
|
RGD |
PMID:12471147 |
RGD:724447 |
NCBI chrNW_004936519:6,166,060...6,180,652
|
|
G |
Il12b |
interleukin 12B |
|
ISO |
mRNA, protein:increased expression:lymph node |
RGD |
PMID:19233473 |
RGD:4831840 |
NCBI chrNW_004936515:4,056,214...4,066,121
|
|
G |
Il13 |
interleukin 13 |
severity |
ISO |
|
RGD |
PMID:7523520 PMID:18250480 |
RGD:5684366 RGD:5684367 |
NCBI chrNW_004936647:2,529,933...2,532,503
|
|
G |
Il16 |
interleukin 16 |
|
ISO |
|
RGD |
PMID:17641011 |
RGD:5024940 |
NCBI chrNW_004936483:19,417,580...19,512,654
|
|
G |
Il17a |
interleukin 17A |
treatment |
ISO |
mRNA, protein:increased expression:lymph node |
RGD |
PMID:16200068 PMID:16785554 PMID:19233473 PMID:20003332 |
RGD:4831840 RGD:4888522 RGD:4889113 RGD:9212317 |
NCBI chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
mRNA:increased expression:spinal cord |
RGD |
PMID:9834127 PMID:9846824 |
RGD:4889542 RGD:4889543 |
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
ISO |
mRNA:increased expression:lymph node |
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chrNW_004936713:1,038,985...1,075,770
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:7593560 |
RGD:8551836 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
|
RGD |
PMID:18997868 |
RGD:5147399 |
NCBI chrNW_004936662:1,689,879...1,696,883
|
|
G |
Il21r |
interleukin 21 receptor |
disease_progression no_association |
ISO |
|
RGD |
PMID:18353312 PMID:18546146 |
RGD:6892939 RGD:6892940 |
NCBI chrNW_004936501:11,100,170...11,112,112
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
|
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chrNW_004936545:6,227,118...6,231,745
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
protein:decreased expression:blood serum (mouse) |
RGD |
PMID:33403844 |
RGD:126790527 |
NCBI chrNW_004936501:11,972,715...11,978,152
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:19269041 |
RGD:2311529 |
NCBI chrNW_004936484:8,514,333...8,555,392
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:oligodendrocytes (rat) |
RGD |
PMID:9358769 PMID:23322593 |
RGD:12791289 RGD:2307412 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Itga4 |
integrin subunit alpha 4 |
susceptibility treatment |
ISO |
rat bone marrow cells in a mouse model |
RGD |
PMID:12626659 PMID:18722022 |
RGD:9698418 RGD:9698436 |
NCBI chrNW_004936509:10,215,283...10,293,653
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:17947672 |
RGD:6482235 |
NCBI chrNW_004936485:8,857,688...8,894,270
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
|
RGD |
PMID:22066025 |
RGD:6483041 |
NCBI chrNW_004936503:111,722...243,627
|
|
G |
Jak3 |
Janus kinase 3 |
treatment |
ISO |
|
RGD |
PMID:25012120 |
RGD:11533939 |
NCBI chrNW_004936596:3,212,593...3,224,426
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
|
RGD |
PMID:19233483 |
RGD:5684404 |
NCBI chrNW_004936482:17,537,697...17,581,320
|
|
G |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
|
RGD |
PMID:25972476 |
RGD:12910744 |
NCBI chrNW_004936482:17,162,854...17,238,319
|
|
G |
LOC101959212 |
alpha-2-macroglobulin |
treatment |
ISO |
|
RGD |
PMID:1710603 |
RGD:10046021 |
NCBI chrNW_004936870:424,832...468,303
|
|
G |
LOC101960095 |
antileukoproteinase |
treatment |
ISO |
|
RGD |
PMID:22436018 |
RGD:9999395 |
NCBI chrNW_004936514:7,618,382...7,620,790
|
|
G |
LOC101964209 |
C-C chemokine receptor type 1 |
|
ISO |
|
RGD |
PMID:14512166 PMID:14655765 |
RGD:5688165 RGD:5688167 |
NCBI chrNW_004936596:177,774...183,186
|
|
G |
LOC101968920 |
eotaxin |
|
ISO |
mRNA:increased expression:lymph node |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chrNW_004936538:835,436...848,907
|
|
G |
LOC101969065 |
mamu class II histocompatibility antigen, DR alpha chain |
|
ISO |
|
RGD |
PMID:8676084 |
RGD:5490166 |
NCBI chrNW_004936727:540,225...544,968
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
|
ISO |
protein:increased expression:cerebellum, spinal cord |
RGD |
PMID:19299462 |
RGD:13800552 |
NCBI chrNW_004936646:1,326,900...1,407,236
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
mRNA:increased expression:brain mRNA:increased expression:spinal cord |
RGD |
PMID:7593556 PMID:9184655 |
RGD:1625038 RGD:4143220 |
NCBI chrNW_004936727:1,940,081...1,941,022
|
|
G |
Mapt |
microtubule associated protein tau |
treatment |
ISO |
|
RGD |
PMID:15494405 |
RGD:1358431 |
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G |
Mbp |
myelin basic protein |
|
ISO |
CTD Direct Evidence: marker/mechanism human sequence peptide in a rat model; associated with Herpesviridae infections |
CTD RGD |
PMID:11501064 PMID:12811845 PMID:15159442 PMID:16285900 PMID:17884951 PMID:24070732 More...
|
RGD:30296670 RGD:7349334 |
NCBI chrNW_004936616:2,082,154...2,159,028
|
|
G |
Mdk |
midkine |
|
ISO |
|
RGD |
PMID:9814819 |
RGD:9831448 |
NCBI chrNW_004936562:2,687,825...2,690,292
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
|
RGD |
PMID:19922364 |
RGD:2325703 |
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
ISO |
|
RGD |
PMID:9549496 |
RGD:8547909 |
NCBI chrNW_004936551:5,388,456...5,395,071
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
protein:increased expression:multiple tissues |
RGD |
PMID:9549496 PMID:20810258 PMID:22800566 PMID:24797785 |
RGD:13204762 RGD:13204801 RGD:8547909 RGD:8547936 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Mobp |
myelin associated oligodendrocyte basic protein |
|
ISO |
|
RGD |
PMID:10623862 |
RGD:27226694 |
NCBI chrNW_004936473:28,663,986...28,709,394
|
|
G |
Mog |
myelin oligodendrocyte glycoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10384097 PMID:12799014 PMID:12904460 PMID:14624757 PMID:16931536 PMID:17654737 PMID:17728465 PMID:18566399 PMID:18667803 PMID:21068375 PMID:21317386 PMID:21341682 PMID:23360710 PMID:23547115 PMID:23639249 PMID:30661753 More...
|
RGD:9685372 RGD:9685373 RGD:9685375 |
NCBI chrNW_004936723:1,070,071...1,112,487
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
mRNA:increased expression:brain (mouse) |
RGD |
PMID:19619133 |
RGD:6484112 |
NCBI chrNW_004936475:8,864,512...8,866,516
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:hippocampus |
RGD |
PMID:17064783 |
RGD:40924670 |
NCBI chrNW_004936612:1,262,557...1,556,281
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
protein:increased expression:cerebrospinal fluid, spinal cord |
RGD |
PMID:16182933 |
RGD:2299007 |
NCBI chrNW_004936757:1,642,122...1,646,499
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19910389 |
|
NCBI chrNW_004936509:6,589,967...6,621,171
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
protein, mRNA:increased expression:thalamus and cortex, CNS |
RGD |
PMID:8866783 |
RGD:5508386 |
NCBI chrNW_004936627:635,784...641,290
|
|
G |
Ngfr |
nerve growth factor receptor |
severity |
ISO |
mRNA:increased expression:central nervous system |
RGD |
PMID:8866783 PMID:16519950 |
RGD:5508312 RGD:5508386 |
NCBI chrNW_004936490:12,038,500...12,057,257
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:21857957 |
RGD:5509069 |
NCBI chrNW_004936538:4,052,277...4,097,051
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1 group H member 2 |
|
ISO |
|
RGD |
PMID:21266776 |
RGD:6480877 |
NCBI chrNW_004936889:223,137...229,968
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
|
ISO |
|
RGD |
PMID:17322387 |
RGD:4892331 |
NCBI chrNW_004936504:10,960,069...11,056,834
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
ISO |
mRNA:increased expression:brain subventricular zone: |
RGD |
PMID:15589512 |
RGD:5684777 |
NCBI chrNW_004936580:6,002,168...6,021,690
|
|
G |
Olig1 |
oligodendrocyte transcription factor 1 |
treatment |
ISO |
|
RGD |
PMID:24941845 |
RGD:40902822 |
NCBI chrNW_004936500:9,208,932...9,211,182
|
|
G |
Olig2 |
oligodendrocyte transcription factor 2 |
treatment |
ISO |
|
RGD |
PMID:24941845 PMID:29682587 |
RGD:40902822 RGD:40902863 |
NCBI chrNW_004936500:9,244,595...9,247,756
|
|
G |
Pdcd1 |
programmed cell death 1 |
susceptibility |
ISO |
|
RGD |
PMID:24648472 |
RGD:40818258 |
NCBI chrNW_004936745:152,571...163,712
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
treatment |
ISO |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chrNW_004936492:2,353,840...2,368,573
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
treatment |
ISO |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chrNW_004936482:16,804,129...16,853,539
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
treatment |
ISO |
|
RGD |
PMID:16042218 |
RGD:11080975 |
NCBI chrNW_004936504:4,762,251...4,799,789
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:20303183 |
RGD:6482686 |
NCBI chrNW_004936479:17,084,006...17,112,264
|
|
G |
Plp1 |
proteolipid protein 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21068375 PMID:24941845 |
RGD:40902822 |
NCBI chrNW_004936499:10,534,953...10,553,411
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17261635 |
|
NCBI chrNW_004936629:3,672,445...3,725,645
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:20708278 |
RGD:6482806 |
NCBI chrNW_004936521:8,057,874...8,060,695
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
severity |
ISO |
|
RGD |
PMID:19486896 |
RGD:6484540 |
NCBI chrNW_004936518:1,817,051...1,843,376
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
protein:increased expression:microglia, macrophage, protein:increased expression:cerebral cortex, cerebellum, spinal cord |
RGD |
PMID:10229132 PMID:21667309 |
RGD:5688149 RGD:5688250 |
NCBI chrNW_004936487:10,745,465...10,758,812
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:cerebral cortex, cerebellum, spinal cord protein:increased expression:endothelial cell |
RGD |
PMID:10229132 PMID:21667309 |
RGD:5688149 RGD:5688250 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Ptn |
pleiotrophin |
|
ISO |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:9814819 |
RGD:9831448 |
NCBI chrNW_004936592:1,706,979...1,806,345
|
|
G |
Qki |
QKI, KH domain containing RNA binding |
|
ISO |
|
RGD |
PMID:22740327 |
RGD:10045997 |
NCBI chrNW_004936489:13,901,066...14,000,652
|
|
G |
Rangrf |
RAN guanine nucleotide release factor |
|
ISO |
|
RGD |
PMID:8557821 |
RGD:6771380 |
NCBI chrNW_004936595:1,513,855...1,515,300
|
|
G |
Rhoa |
ras homolog family member A |
severity |
ISO |
protein:increased expression:microglial cell, brain |
RGD |
PMID:17983427 |
RGD:2298887 |
NCBI chrNW_004936529:1,000,050...1,045,655
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
mRNA,protein:increased expression,increased activity:spinal cord, astrocyte: |
RGD |
PMID:11733372 |
RGD:13208549 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
|
RGD |
PMID:15892298 PMID:18991353 |
RGD:12801423 RGD:12801440 |
NCBI chrNW_004936527:10,033,095...10,042,713
|
|
G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chrNW_004936524:2,717,885...2,720,874
|
|
G |
Sirt1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23547115 |
|
NCBI chrNW_004936521:10,296,097...10,316,673
|
|
G |
Sncb |
synuclein beta |
|
ISO |
|
RGD |
PMID:12496452 |
RGD:730073 |
NCBI chrNW_004936597:878,270...888,346
|
|
G |
Srsf9 |
serine and arginine rich splicing factor 9 |
treatment |
ISO |
|
RGD |
PMID:20616573 |
RGD:11040805 |
NCBI chrNW_004936668:484,922...491,576
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
|
RGD |
PMID:22066025 |
RGD:6483041 |
NCBI chrNW_004936506:7,196,860...7,235,854
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:17878325 PMID:22066025 |
RGD:6483041 RGD:6892946 |
NCBI chrNW_004936490:17,119,189...17,178,402
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
|
RGD |
PMID:11240014 |
RGD:7207888 |
NCBI chrNW_004936506:7,091,982...7,185,938
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
mRNA, protein:increased expression:central nervous system |
RGD |
PMID:17204936 |
RGD:2302088 |
NCBI chrNW_004936661:3,742,080...3,758,266
|
|
G |
Tgfb2 |
transforming growth factor beta 2 |
|
ISO |
mRNA, protein:decreased expression:central nervous system |
RGD |
PMID:17204936 |
RGD:2302088 |
NCBI chrNW_004936628:310,720...394,002
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:15878627 |
RGD:1559178 |
NCBI chrNW_004936492:6,996,627...7,046,137
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:18644848 |
RGD:2312575 |
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
protein:increased expression:spinal cord |
RGD |
PMID:18644848 |
RGD:2312575 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:11421579 |
RGD:12904661 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:12196270 |
RGD:1580348 |
NCBI chrNW_004936748:785,491...802,791
|
|
G |
Vdr |
vitamin D receptor |
treatment |
ISO |
|
RGD |
PMID:21287548 PMID:21318047 |
RGD:13210791 RGD:8158064 |
NCBI chrNW_004936512:5,741,836...5,800,999
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
mRNA:decreased expression:Cerebrospinal Fluid: mRNA,protein:decreased expression:spinal cord: |
RGD |
PMID:12387457 PMID:17083617 |
RGD:634258 RGD:7421596 |
NCBI chrNW_004936476:16,245,134...16,261,180
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:20978211 |
RGD:5685386 |
NCBI chrNW_004936489:5,425,778...5,434,483
|
|
G |
Xbp1 |
X-box binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chrNW_004936657:2,891,171...2,895,409
|
|
|
G |
Acan |
aggrecan |
|
ISO |
protein:altered expression:central nervous system, plaque (human) |
RGD |
PMID:11764092 |
RGD:2315836 |
NCBI chrNW_004936483:14,811,152...14,846,305
|
|
G |
Ache |
acetylcholinesterase (Cartwright blood group) |
|
ISO |
protein:decreased expression:cerebrospinal fluid |
RGD |
PMID:2953866 |
RGD:5688127 |
NCBI chrNW_004936543:856,678...862,080
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20714168 |
RGD:5686885 |
NCBI chrNW_004936578:3,168,599...3,179,369
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
susceptibility |
ISO |
DNA:polymorphism:cds:p.G82S rs2070600 (human) |
RGD |
PMID:21511691 |
RGD:6767562 |
NCBI chrNW_004936727:1,418,342...1,422,005
|
|
G |
Agt |
angiotensinogen |
|
ISO |
protein:decreased expression:brain,astrocyte: |
RGD |
PMID:17715340 |
RGD:13432361 |
NCBI chrNW_004936484:19,713,299...19,721,144
|
|
G |
Aim2 |
absent in melanoma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936740:1,447,869...1,460,836
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:increased expression: serum |
RGD |
PMID:20350318 |
RGD:5508215 |
NCBI chrNW_004936542:2,111,055...2,112,626
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
|
RGD |
PMID:10335523 |
RGD:1358408 |
NCBI chrNW_004936706:1,531,219...1,531,921
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15048896 |
|
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
|
ISO |
mRNA:increased expression:white matter |
RGD |
PMID:25216636 |
RGD:14390079 |
NCBI chrNW_004936514:4,719,198...4,736,638
|
|
G |
B4galt6 |
beta-1,4-galactosyltransferase 6 |
|
ISO |
mRNA:increased expression:white matter |
RGD |
PMID:25216636 |
RGD:14390079 |
NCBI chrNW_004936682:1,535,617...1,590,723
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20122907 |
|
NCBI chrNW_004936707:1,784,338...1,913,401
|
|
G |
Bdnf |
brain derived neurotrophic factor |
onset |
ISO |
protein:decreased expression:serum |
RGD |
PMID:20656764 |
RGD:5684915 |
NCBI chrNW_004936540:5,530,081...5,582,765
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
|
ISO |
|
RGD |
PMID:11353727 |
RGD:1580151 |
NCBI chrNW_004936669:133,488...308,623
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
DNA:repeats, haplotypes:multiple |
RGD |
PMID:19828204 |
RGD:8661778 |
NCBI chrNW_004936589:2,504,235...2,536,778
|
|
G |
Cblb |
Cbl proto-oncogene B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20453840 |
|
NCBI chrNW_004936701:1,157,790...1,353,375
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human) |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chrNW_004936538:781,687...784,199
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936525:8,238,128...8,240,974
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:brain, frontal cortex (human) |
RGD |
PMID:11091283 |
RGD:4890028 |
NCBI chrNW_004936490:253,279...259,947
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:21427490 |
RGD:6892919 |
NCBI chrNW_004936596:223,660...224,739
|
|
G |
Cd28 |
CD28 molecule |
|
ISO |
DNA:SNP:promoter:-372G>A (human) |
RGD |
PMID:14975605 |
RGD:1358478 |
NCBI chrNW_004936631:335,411...363,407
|
|
G |
Cd40 |
CD40 molecule |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) |
CTD RGD |
PMID:19525955 PMID:20190274 PMID:20634952 |
RGD:5490971 RGD:5490975 |
NCBI chrNW_004936514:6,936,915...6,947,246
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936533:2,949,026...3,033,166
|
|
G |
Cd46 |
CD46 molecule |
|
ISO |
|
RGD |
PMID:21177319 |
RGD:6483460 |
NCBI chrNW_004936557:5,136,784...5,175,543
|
|
G |
Cd6 |
CD6 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19525953 PMID:24076602 |
|
NCBI chrNW_004936581:1,932,596...1,943,671
|
|
G |
Cd86 |
CD86 molecule |
susceptibility |
ISO |
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human) |
RGD |
PMID:26531698 |
RGD:11354964 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Cd96 |
CD96 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936834:432,538...522,118
|
|
G |
Cdk17 |
cyclin dependent kinase 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936507:12,317,746...12,409,506
|
|
G |
Ciita |
class II major histocompatibility complex transactivator |
susceptibility no_association |
ISO |
DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:-168A>G DNA:polymorphism:promoter:rs3087456, no association in a German cohort |
RGD |
PMID:15821736 PMID:16426246 PMID:21653641 |
RGD:1358146 RGD:5491175 RGD:5491189 |
NCBI chrNW_004936530:9,033,510...9,073,341
|
|
G |
Cldn11 |
claudin 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25911099 |
|
NCBI chrNW_004936593:2,072,368...2,087,820
|
|
G |
Clec16a |
C-type lectin domain containing 16A |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:g.194570G>A, rs7184083 |
CTD RGD |
PMID:18946483 PMID:19525955 PMID:21653641 |
RGD:5491175 |
NCBI chrNW_004936530:9,089,478...9,264,563
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
|
ISO |
mRNA:altered expression:PMN cell (human) |
RGD |
PMID:20136355 |
RGD:5133255 |
NCBI chrNW_004936532:3,896,654...3,908,184
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
ISO |
|
RGD |
PMID:18676363 PMID:19473295 |
RGD:6483339 RGD:6483346 |
NCBI chrNW_004936490:16,834,570...16,841,734
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12876144 |
|
NCBI chrNW_004936510:3,779,930...3,806,615
|
|
G |
Cntf |
ciliary neurotrophic factor |
onset |
ISO |
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein |
RGD |
PMID:11890844 |
RGD:1626112 |
NCBI chrNW_004936581:3,710,171...3,715,753
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
mRNA:increased expression:brain |
RGD |
PMID:20456365 |
RGD:5688302 |
NCBI chrNW_004936490:11,448,552...11,465,836
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
no_association |
ISO |
DNA:SNPs: :rs3087243,rs11571302(human) DNA:SNP:CDS:49A>G (human) |
RGD |
PMID:10082437 PMID:17942509 PMID:19740340 |
RGD:1358538 RGD:2301975 RGD:7411672 |
NCBI chrNW_004936631:484,356...489,643
|
|
G |
Ctsh |
cathepsin H |
|
ISO |
|
RGD |
PMID:17086443 |
RGD:5686392 |
NCBI chrNW_004936471:37,135,200...37,156,081
|
|
G |
Ctsl |
cathepsin L |
|
ISO |
|
RGD |
PMID:17086443 |
RGD:5686392 |
NCBI chrNW_004936680:3,047,355...3,050,640
|
|
G |
Dnaaf11 |
dynein axonemal assembly factor 11 |
|
ISO |
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936470:16,557,381...16,640,519
|
|
G |
Dusp28 |
dual specificity phosphatase 28 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936745:1,063,365...1,064,590
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:12646761 |
RGD:8661710 |
NCBI chrNW_004936534:885,489...892,292
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chrNW_004936541:4,613,197...4,705,911
|
|
G |
Fas |
Fas cell surface death receptor |
susceptibility |
ISO |
DNA:polymorphism:promoter:-670A>G (human) protein:increased expression:white matter of brain: |
RGD |
PMID:8879222 PMID:12098516 |
RGD:12903947 RGD:12903986 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
|
ISO |
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11438180 PMID:31068361 |
RGD:1358622 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
no_association |
ISO |
DNA:polymorphism: :p.H131R (human) |
RGD |
PMID:12864991 |
RGD:5147977 |
NCBI chrNW_004937131:15,542...22,099
|
|
G |
Gabra3 |
gamma-aminobutyric acid type A receptor subunit alpha3 |
|
ISO |
DNA:repeat::(CA)11-16 (human) |
RGD |
PMID:9561979 |
RGD:1358628 |
NCBI chrNW_004936714:461,050...675,745
|
|
G |
Gc |
GC vitamin D binding protein |
no_association susceptibility |
ISO |
protein:decreased expression:cerebrospinal fluid DNA:SNPs:exon:p.T420K, D416E(human) CTD Direct Evidence: marker/mechanism protein:increased expression:plasma: |
RGD CTD |
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278 |
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923 |
NCBI chrNW_004936598:3,220,029...3,256,091
|
|
G |
Gli1 |
GLI family zinc finger 1 |
|
ISO |
|
RGD |
PMID:18991353 |
RGD:12801440 |
NCBI chrNW_004936646:1,622,308...1,629,787
|
|
G |
Grm8 |
glutamate metabotropic receptor 8 |
|
ISO |
protein:increased expression:astrocyte, microglia, macrophage |
RGD |
PMID:15589052 |
RGD:6771187 |
NCBI chrNW_004936479:13,768,014...14,504,387
|
|
G |
Grn |
granulin precursor |
|
ISO |
protein:increased expression:macrophage, microglia |
RGD |
PMID:21613335 |
RGD:5509591 |
NCBI chrNW_004936541:793,548...800,271
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
disease_progression |
ISO |
DNA:polymorphism:exon: |
RGD |
PMID:10680782 |
RGD:5490267 |
NCBI chrNW_004936704:1,233,909...1,236,864
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
disease_progression |
ISO |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:10680782 |
RGD:5490267 |
NCBI chrNW_004936599:2,197,681...2,200,642
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase |
|
ISO |
DNA:SNP:exon: rs17368528 (human) |
RGD |
PMID:19935835 |
RGD:6784513 |
NCBI chrNW_004936623:3,359,624...3,376,598
|
|
G |
Hdac1 |
histone deacetylase 1 |
|
ISO |
protein:increased expression:cytoplasm: |
RGD |
PMID:20037577 |
RGD:9590131 |
NCBI chrNW_004936474:15,320,635...15,351,418
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
|
ISO |
|
RGD |
PMID:14688203 |
RGD:5686803 |
NCBI chrNW_004936476:15,830,459...15,836,994
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
protein: increased expression: cerebrospinal fluid |
RGD |
PMID:16303141 |
RGD:6480236 |
NCBI chrNW_004936542:7,577,192...7,581,598
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20175758 |
|
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Ifnb1 |
interferon beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10520943 PMID:12424511 PMID:12432978 PMID:23517930 PMID:27806875 |
|
NCBI chrNW_004936652:2,736,270...2,736,833
|
|
G |
Ifng |
interferon gamma |
susceptibility |
ISO |
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9818947 PMID:23517930 |
RGD:1358738 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Igf2 |
insulin like growth factor 2 |
|
ISO |
protein:increased expression:macrophage |
RGD |
PMID:10417663 |
RGD:5510017 |
NCBI chrNW_004936816:972,902...981,232
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23517930 |
|
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24076602 |
|
NCBI chrNW_004936519:6,166,060...6,180,652
|
|
G |
Il13 |
interleukin 13 |
severity |
ISO |
protein:increased expression:serum protein:increased expression:cerebrospinal fluid |
RGD |
PMID:21677024 PMID:22031307 |
RGD:5684368 RGD:8549589 |
NCBI chrNW_004936647:2,529,933...2,532,503
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21455110 PMID:23517930 |
RGD:8698672 |
NCBI chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il1b |
interleukin 1 beta |
severity |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:10025794 PMID:15210533 PMID:25458313 |
RGD:1358741 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25458313 |
|
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
DNA:polymorphisms: : |
RGD |
PMID:20072140 PMID:21281812 |
RGD:6892695 RGD:6892963 |
NCBI chrNW_004936501:11,100,170...11,112,112
|
|
G |
Il23r |
interleukin 23 receptor |
no_association |
ISO |
DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human) DNA:SNPs: :rs2201841,rs10889677,s7517847(human) |
RGD |
PMID:18368064 PMID:24547735 |
RGD:8549631 RGD:8549632 |
NCBI chrNW_004936591:4,365,598...4,425,053
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602 |
RGD:2311526 |
NCBI chrNW_004936484:8,514,333...8,555,392
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
|
RGD |
PMID:14712310 |
RGD:4890395 |
NCBI chrNW_004936501:11,025,590...11,058,807
|
|
G |
Il6 |
interleukin 6 |
treatment severity |
ISO |
DNA:polymorphism:promoter:-174G>C(human) DNA:polymorphism:promoter:-572 G>C(human) |
RGD |
PMID:23202972 PMID:24155968 PMID:26285213 |
RGD:11079567 RGD:12791288 RGD:12792202 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Il7 |
interleukin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17660816 |
|
NCBI chrNW_004936702:110,625...162,957
|
|
G |
Il7r |
interleukin 7 receptor |
|
ISO |
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3 |
ClinVar |
PMID:24759676 PMID:25046553 PMID:25741868 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
|
|
NCBI chrNW_004936518:5,815,820...5,842,571
|
|
G |
Irf5 |
interferon regulatory factor 5 |
susceptibility |
ISO |
DNA:SNPs: :rs3807306, rs4728142 (human) |
RGD |
PMID:20861862 PMID:25392335 |
RGD:11055911 RGD:40924643 |
NCBI chrNW_004936579:6,138,372...6,149,531
|
|
G |
Irf8 |
interferon regulatory factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19525953 |
|
NCBI chrNW_004936641:2,608,109...2,622,446
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
disease_progression |
ISO |
|
RGD |
PMID:16934875 PMID:20805994 |
RGD:6482233 RGD:6482240 |
NCBI chrNW_004936485:8,857,688...8,894,270
|
|
G |
Jarid2 |
jumonji and AT-rich interaction domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936552:1,566,382...1,786,837
|
|
G |
Kcnj10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24070676 |
|
NCBI chrNW_004936740:555,948...589,219
|
|
G |
Kif1b |
kinesin family member 1B |
susceptibility no_association |
ISO |
DNA:snp:intron:c.1590+932T>C (rs10492972) (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18997785 PMID:20502484 |
RGD:12738462 RGD:12738463 |
NCBI chrNW_004936623:4,091,093...4,222,510
|
|
G |
Kif5a |
kinesin family member 5A |
susceptibility |
ISO |
DNA:snp:intron:c.1717-152C>G (rs1678542) (human) |
RGD |
PMID:20508602 |
RGD:12793067 |
NCBI chrNW_004936646:1,697,531...1,730,376
|
|
G |
Klhl6 |
kelch like family member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936578:6,226,533...6,284,343
|
|
G |
Klk6 |
kallikrein related peptidase 6 |
|
ISO |
|
RGD |
PMID:11802715 |
RGD:2314867 |
NCBI chrNW_004936889:621,645...628,454
|
|
G |
LOC101955076 |
low affinity immunoglobulin gamma Fc region receptor III-A |
disease_progression |
ISO |
protein:increased expression:gamma-delta T cell |
RGD |
PMID:18155780 |
RGD:5508375 |
NCBI chrNW_004937131:42,523...49,533
|
|
G |
LOC101959212 |
alpha-2-macroglobulin |
|
ISO |
|
RGD |
PMID:11498265 |
RGD:1549857 |
NCBI chrNW_004936870:424,832...468,303
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DPB1*0501 (human) DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human) |
CTD RGD |
PMID:17125797 PMID:17956852 PMID:32560041 |
RGD:150429801 RGD:150429806 |
NCBI chrNW_004936476:25,730,800...25,741,089
|
|
G |
LOC101964975 |
interleukin-8 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20138139 |
RGD:5134999 |
NCBI chrNW_004936598:1,779,471...1,781,353
|
|
G |
LOC101968601 |
signal transducer CD24 |
|
ISO |
|
RGD |
PMID:14657362 |
RGD:1358462 |
NCBI chrNW_004936491:16,706,745...16,707,010
|
|
G |
LOC101969065 |
mamu class II histocompatibility antigen, DR alpha chain |
|
ISO |
DNA:polymorphism:promoter (human) DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10527398 PMID:17660530 PMID:19834503 |
RGD:5490159 RGD:5490202 RGD:5490204 |
NCBI chrNW_004936727:540,225...544,968
|
|
G |
Lrrc8c |
leucine rich repeat containing 8 VRAC subunit C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936537:9,050,495...9,124,649
|
|
G |
Mag |
myelin associated glycoprotein |
|
ISO |
|
RGD |
PMID:2419505 |
RGD:9685292 |
NCBI chrNW_004936570:989,743...1,004,820
|
|
G |
Mbp |
myelin basic protein |
|
ISO |
|
RGD |
PMID:1691612 |
RGD:1358488 |
NCBI chrNW_004936616:2,082,154...2,159,028
|
|
G |
Mcam |
melanoma cell adhesion molecule |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23595028 |
|
NCBI chrNW_004936542:4,235,914...4,244,981
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
susceptibility |
ISO |
DNA:SNP:promoter:-82A>G (human) |
RGD |
PMID:19628284 |
RGD:13204795 |
NCBI chrNW_004936551:5,107,567...5,117,843
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
no_association susceptibility |
ISO |
DNA:repeat, SNP:promoter mRNA:increased expression:blood, mononuclear cell DNA:SNP:promoter:-1562C>T (human) DNA:SNP, repeat:promoter:-1562C>T (human) |
RGD |
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127 |
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Mog |
myelin oligodendrocyte glycoprotein |
|
ISO |
|
RGD |
PMID:17142321 |
RGD:9685374 |
NCBI chrNW_004936723:1,070,071...1,112,487
|
|
G |
Mphosph9 |
M-phase phosphoprotein 9 |
susceptibility |
ISO |
DNA:snp:intron:122222678G>T rs1790100 (human) |
RGD |
PMID:19879194 |
RGD:2316985 |
NCBI chrNW_004936558:1,483,112...1,536,804
|
|
G |
Nabp1 |
nucleic acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936506:6,608,333...6,616,076
|
|
G |
Ndufs2 |
NADH:ubiquinone oxidoreductase core subunit S2 |
|
ISO |
|
RGD |
PMID:18682780 |
RGD:6482255 |
NCBI chrNW_004936903:503,633...514,235
|
|
G |
Nectin2 |
nectin cell adhesion molecule 2 |
no_association severity |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) |
CTD RGD |
PMID:16738668 PMID:17376543 |
RGD:6767558 RGD:6767565 |
NCBI chrNW_004936706:1,470,910...1,498,986
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936534:1,816,755...1,863,200
|
|
G |
Nefh |
neurofilament heavy chain |
severity |
ISO |
|
RGD |
PMID:16764346 |
RGD:27226808 |
NCBI chrNW_004936657:3,443,406...3,453,096
|
|
G |
Nefl |
neurofilament light chain |
disease_progression |
ISO |
protein:increased expression:serum (human) protein:increased expresssion:serum (human) |
RGD |
PMID:31383792 PMID:33317883 |
RGD:127284875 RGD:127285024 |
NCBI chrNW_004936757:1,642,122...1,646,499
|
|
G |
Ngfr |
nerve growth factor receptor |
|
ISO |
protein:increased expression:reactive astrocytes, microglia/macrophages |
RGD |
PMID:11829348 |
RGD:5508481 |
NCBI chrNW_004936490:12,038,500...12,057,257
|
|
G |
Nlrp3 |
NLR family pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25458313 |
|
NCBI chrNW_004936864:709,693...732,119
|
|
G |
Notch4 |
notch receptor 4 |
|
ISO |
DNA: snps: cds: rs422951 |
RGD |
PMID:21654846 |
RGD:6480692 |
NCBI chrNW_004936727:1,386,842...1,409,823
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1 group H member 3 |
|
ISO |
ClinVar Annotator: match by term: Multiple sclerosis |
ClinVar |
PMID:27253448 |
|
NCBI chrNW_004936562:1,937,665...1,946,680
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17728465 |
|
NCBI chrNW_004936558:3,106,819...3,149,689
|
|
G |
Pdcd1 |
programmed cell death 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression |
OMIM ClinVar |
PMID:12402038 PMID:15912506 |
|
NCBI chrNW_004936745:152,571...163,712
|
|
G |
Phactr2 |
phosphatase and actin regulator 2 |
|
ISO |
DNA: snp: : rs1015340 |
RGD |
PMID:20546594 |
RGD:6483093 |
NCBI chrNW_004936625:2,336,455...2,474,032
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:22246459 |
RGD:6482783 |
NCBI chrNW_004936476:13,609,847...13,646,174
|
|
G |
Pnmt |
phenylethanolamine N-methyltransferase |
|
ISO |
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human) |
RGD |
PMID:11958827 |
RGD:1358561 |
NCBI chrNW_004936490:14,858,682...14,861,614
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
|
ISO |
DNA:missense mutations:cds: |
RGD |
PMID:20837861 |
RGD:8694283 |
NCBI chrNW_004936483:15,178,947...15,196,277
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:2843795 PMID:9664777 |
|
NCBI chrNW_004936493:7,060,747...7,065,276
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
protein:increased expression:blood, T cell DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) |
RGD |
PMID:19680139 PMID:20921521 PMID:22001684 |
RGD:6482805 RGD:6482817 RGD:6482820 |
NCBI chrNW_004936521:8,057,874...8,060,695
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
protein:increased expression:white matter,astrocyte: |
RGD |
PMID:19716418 |
RGD:10412736 |
NCBI chrNW_004936489:12,118,538...12,913,664
|
|
G |
Prnp |
prion protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936485:14,104,829...14,118,614
|
|
G |
Psmb9 |
proteasome 20S subunit beta 9 |
|
ISO |
|
RGD |
PMID:20174631 |
RGD:6483446 |
NCBI chrNW_004936476:25,894,313...25,899,132
|
|
G |
Ptpn22 |
protein tyrosine phosphatase non-receptor type 22 |
no_association |
ISO |
DNA:missense mutation: :R620W (rs2476601) (human) |
RGD |
PMID:15934099 |
RGD:6484550 |
NCBI chrNW_004936690:2,180,804...2,232,869
|
|
G |
Ptprc |
protein tyrosine phosphatase receptor type C |
|
ISO |
DNA:snp:exon:c.77C>G (human) |
RGD |
PMID:11101853 |
RGD:1358566 |
NCBI chrNW_004936567:5,266,653...5,378,464
|
|
G |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25853421 |
|
NCBI chrNW_004936477:3,354,336...3,445,248
|
|
G |
Rgma |
repulsive guidance molecule BMP co-receptor a |
|
ISO |
DNA:SNPs:intron: (rs997941, rs34925346) (human) |
RGD |
PMID:20072140 |
RGD:6892695 |
NCBI chrNW_004936483:9,753,112...9,792,817
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
protein:increased expression:microglial cell, brain |
RGD |
PMID:17983427 |
RGD:2298887 |
NCBI chrNW_004936529:1,000,050...1,045,655
|
|
G |
Rnf19a |
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936470:42,965,790...43,007,487
|
|
G |
Rnf217 |
ring finger protein 217 |
|
ISO |
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to |
ClinVar |
|
|
NCBI chrNW_004936639:4,295,293...4,325,468
|
|
G |
Sele |
selectin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20175758 |
|
NCBI chrNW_004936481:16,915,203...16,921,840
|
|
G |
Sh2d2a |
SH2 domain containing 2A |
susceptibility |
ISO |
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter |
RGD |
PMID:11528519 PMID:18554728 |
RGD:1358573 RGD:2298871 |
NCBI chrNW_004936580:5,959,971...5,967,250
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
|
RGD |
PMID:18991353 |
RGD:12801440 |
NCBI chrNW_004936527:10,033,095...10,042,713
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
no_association |
ISO |
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human) |
RGD CTD |
PMID:15584484 PMID:16597321 PMID:18973068 |
RGD:5684937 RGD:5684960 |
NCBI chrNW_004936569:888,309...895,991
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum |
RGD |
PMID:11721059 PMID:15885319 |
RGD:1581329 RGD:1581472 |
NCBI chrNW_004936905:148,956...156,023
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24076602 |
|
NCBI chrNW_004936506:7,091,982...7,185,938
|
|
G |
Sys1 |
SYS1 golgi trafficking protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936514:7,518,048...7,529,024
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility no_association |
ISO |
DNA:synonymous mutation: : DNA:SNPs:CDs:p.V379I, A565T(human) |
RGD |
PMID:7759306 PMID:7797617 PMID:7928442 |
RGD:6482279 RGD:6482280 RGD:6482281 |
NCBI chrNW_004936476:25,913,699...25,923,419
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
mRNA:increased expression:cerebrospinal fluid, mononuclear cell |
RGD |
PMID:18644848 |
RGD:2312575 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tnf |
tumor necrosis factor |
no_association disease_progression |
ISO |
DNA:SNP:promoter:-308G>A (human) |
RGD |
PMID:8887999 PMID:8964914 PMID:9270614 |
RGD:12904068 RGD:12904657 RGD:7401237 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24076602 |
|
NCBI chrNW_004936560:5,124,955...5,138,988
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
susceptibility |
ISO |
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5 |
OMIM ClinVar |
PMID:22801493 PMID:24033266 PMID:25326637 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936709:1,407,327...1,421,448
|
|
G |
Tnfsf14 |
TNF superfamily member 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24076602 |
|
NCBI chrNW_004936588:3,976,492...3,979,825
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
|
ISO |
protein:increased expression:plasma, monocyte (human) |
RGD |
PMID:16970683 |
RGD:2317352 |
NCBI chrNW_004936588:3,844,924...3,847,218
|
|
G |
Traf1 |
TNF receptor associated factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936487:9,349,883...9,368,946
|
|
G |
Tyk2 |
tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19525955 |
|
NCBI chrNW_004936659:681,463...704,484
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20175758 |
|
NCBI chrNW_004936748:785,491...802,791
|
|
G |
Vdr |
vitamin D receptor |
no_association susceptibility |
ISO |
DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:polymorphisms: :rs731236,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563 |
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559 |
NCBI chrNW_004936512:5,741,836...5,800,999
|
|
G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068361 |
|
NCBI chrNW_004936602:3,135,790...3,140,622
|
|
G |
Xbp1 |
X-box binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chrNW_004936657:2,891,171...2,895,409
|
|
|
G |
Aqp4 |
aquaporin 4 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-1003A>G(human) associated withHiccup; |
RGD CTD |
PMID:16087714 PMID:18420727 PMID:18509235 PMID:20047900 PMID:22271321 PMID:23116879 PMID:23890015 PMID:23995423 PMID:24070676 More...
|
RGD:5148024 RGD:5148032 RGD:8695993 RGD:8696026 RGD:8696032 RGD:8696033 RGD:8696034 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
G |
Cd59 |
CD59 molecule (CD59 blood group) |
severity |
ISO |
|
RGD |
PMID:28212662 |
RGD:13792592 |
NCBI chrNW_004936533:4,242,589...4,263,136
|
|
G |
Gfap |
glial fibrillary acidic protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18509235 |
|
NCBI chrNW_004936541:1,265,915...1,275,232
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
protein:increased expression:cerebrospinal fluid (human) |
RGD |
PMID:23041403 |
RGD:127285589 |
NCBI chrNW_004936662:1,689,879...1,696,883
|
|
G |
Il6 |
interleukin 6 |
severity |
ISO |
protein:increased expression:serum, cerebral spinal fluid: |
RGD |
PMID:20128675 |
RGD:7829722 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Mbp |
myelin basic protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18509235 |
|
NCBI chrNW_004936616:2,082,154...2,159,028
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21621856 |
RGD:8547883 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Nefh |
neurofilament heavy chain |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:23316360 |
RGD:27226805 |
NCBI chrNW_004936657:3,443,406...3,453,096
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:33317883 |
RGD:127285024 |
NCBI chrNW_004936757:1,642,122...1,646,499
|
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
|
RGD |
PMID:17468440 |
RGD:8698645 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif 14 |
|
ISO |
DNA:SNPs:intron: A>G, C>G (human) |
RGD |
PMID:15913795 |
RGD:6771190 |
NCBI chrNW_004936521:7,951,176...8,025,666
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
|
RGD |
PMID:20122907 |
RGD:5687690 |
NCBI chrNW_004936707:1,784,338...1,913,401
|
|
G |
Cd274 |
CD274 molecule |
severity |
ISO |
|
RGD |
PMID:21494618 |
RGD:6893669 |
NCBI chrNW_004936539:132,870...145,288
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
protein:increased expression:cerebrospinal fluid: |
RGD |
PMID:20093204 |
RGD:5509869 |
NCBI chrNW_004936598:3,220,029...3,256,091
|
|
G |
Grn |
granulin precursor |
susceptibility |
ISO |
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human) |
RGD |
PMID:20463744 PMID:21613335 |
RGD:5509591 RGD:5509596 |
NCBI chrNW_004936541:793,548...800,271
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis |
ClinVar |
|
|
NCBI chrNW_004936512:11,481,017...11,487,737
|
|
G |
Igfbp3 |
insulin like growth factor binding protein 3 |
disease_progression |
ISO |
|
RGD |
PMID:15732261 |
RGD:1626118 |
NCBI chrNW_004936478:20,511,490...20,518,251
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
DNA:missense mutation:cds:p.Q551R (human) |
RGD |
PMID:11164908 |
RGD:1358313 |
NCBI chrNW_004936501:11,025,590...11,058,807
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
|
RGD |
PMID:14504963 |
RGD:13204808 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Primary progressive multiple sclerosis |
ClinVar |
PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004936483:15,178,947...15,196,277
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
|
RGD |
PMID:12926841 |
RGD:12801414 |
NCBI chrNW_004936527:10,033,095...10,042,713
|
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624384 |
|
NCBI chrNW_004936525:1,559,575...1,570,679
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif 14 |
|
ISO |
DNA:SNP:intron: C>T (human) |
RGD |
PMID:15913795 |
RGD:6771190 |
NCBI chrNW_004936521:7,951,176...8,025,666
|
|
G |
Apoa4 |
apolipoprotein A4 |
onset |
ISO |
protein:decreased expression:cerebrospinal fluid (human) |
RGD |
PMID:19383442 |
RGD:5685649 |
NCBI chrNW_004936542:2,098,683...2,101,127
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15096402 PMID:34624384 |
|
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
|
RGD |
PMID:20855355 |
RGD:6893496 |
NCBI chrNW_004936810:791,823...838,303
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
protein:increased expression:blood, B cell |
RGD |
PMID:21310664 |
RGD:6893670 |
NCBI chrNW_004936536:6,462,080...6,483,450
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO |
|
RGD |
PMID:10976643 |
RGD:5686865 |
NCBI chrNW_004936471:34,438,676...34,475,005
|
|
G |
Ctss |
cathepsin S |
|
ISO |
mRNA, protein:increased expression:blood, leukocyte |
RGD |
PMID:21143385 |
RGD:5687146 |
NCBI chrNW_004936580:963,176...991,732
|
|
G |
Fas |
Fas cell surface death receptor |
susceptibility |
ISO |
DNA:polymorphism:intron:735T>C(human) |
RGD |
PMID:15218339 |
RGD:12903953 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Grn |
granulin precursor |
disease_progression |
ISO |
protein:increased expression:cerebrospinal fluids |
RGD |
PMID:21613335 |
RGD:5509591 |
NCBI chrNW_004936541:793,548...800,271
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
|
RGD |
PMID:15153541 |
RGD:5128853 |
NCBI chrNW_004936515:6,030,402...6,051,161
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis |
ClinVar |
|
|
NCBI chrNW_004936512:11,481,017...11,487,737
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
protein: increased expression |
RGD |
PMID:21824468 |
RGD:5688780 |
NCBI chrNW_004936542:7,577,192...7,581,598
|
|
G |
Klc1 |
kinesin light chain 1 |
susceptibility |
ISO |
DNA:SNP:intron:56836G>C (rs8702) (human) |
RGD |
PMID:17999208 |
RGD:5684008 |
NCBI chrNW_004936621:1,471,574...1,505,119
|
|
G |
Mmp19 |
matrix metallopeptidase 19 |
|
ISO |
mRNA:increased expression:mononuclear cell |
RGD |
PMID:11438176 |
RGD:1642025 |
NCBI chrNW_004936646:298,854...304,479
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
|
RGD |
PMID:16412833 |
RGD:13204825 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Nefh |
neurofilament heavy chain |
treatment |
ISO |
|
RGD |
PMID:15222692 |
RGD:27226879 |
NCBI chrNW_004936657:3,443,406...3,453,096
|
|
G |
Nefl |
neurofilament light chain |
|
ISO |
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human) |
RGD |
PMID:30761586 PMID:33658322 |
RGD:127285025 RGD:127285027 |
NCBI chrNW_004936757:1,642,122...1,646,499
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
disease_progression |
ISO |
DNA:SNPs: :rs3135499,rs2066842(human) |
RGD |
PMID:20595247 |
RGD:13204725 |
NCBI chrNW_004936475:3,708,069...3,742,845
|
|
G |
Nog |
noggin |
|
ISO |
mRNA,protein:decreased expression:mononuclear cell" |
RGD |
PMID:21111488 |
RGD:12801480 |
NCBI chrNW_004936490:6,262,651...6,264,069
|
|
G |
Serpine1 |
serpin family E member 1 |
disease_progression |
ISO |
protein:increased expression:plasma: |
RGD |
PMID:10739162 |
RGD:13208510 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
treatment |
ISO |
|
RGD |
PMID:16412833 |
RGD:13204825 |
NCBI chrNW_004936502:13,345,936...13,350,170
|
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:10616010 |
RGD:5024918 |
NCBI chrNW_004936567:1,411,080...1,418,332
|
|
G |
Crh |
corticotropin releasing hormone |
no_association |
ISO |
DNA:polymorphism:promoter |
RGD |
PMID:12051390 |
RGD:1581301 |
NCBI chrNW_004936496:7,759,656...7,761,555
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:blood: |
RGD |
PMID:15206651 |
RGD:9491785 |
NCBI chrNW_004936740:885,855...888,854
|
|
G |
Csf2 |
colony stimulating factor 2 |
|
ISO |
|
RGD |
PMID:9844760 |
RGD:11059502 |
NCBI chrNW_004936647:3,081,896...3,083,864
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
|
ISO |
mRNA:increased expression:temporal artery |
RGD |
PMID:21220737 |
RGD:6482238 |
NCBI chrNW_004937098:212,704...220,589
|
|
G |
Eln |
elastin |
|
ISO |
|
RGD |
PMID:9101501 |
RGD:9585754 |
NCBI chrNW_004936543:3,135,169...3,165,023
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
|
ISO |
DNA:polymorphism: :p.H131R (human) |
RGD |
PMID:16846526 |
RGD:5147974 |
NCBI chrNW_004937131:15,542...22,099
|
|
G |
Ifng |
interferon gamma |
severity |
ISO |
DNA:repeats:intron: |
RGD |
PMID:15675129 |
RGD:8157621 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Il17a |
interleukin 17A |
susceptibility severity |
ISO |
DNA:snps:promoter, 3' utr: c.-197A>G (rs2275913), c.*159A>G (rs7747909) (human) mRNA, protein:increased expression:temporal artery (human) |
RGD |
PMID:22993227 PMID:24919468 |
RGD:8698666 RGD:9068454 |
NCBI chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il18 |
interleukin 18 |
no_association |
ISO |
DNA:SNPs:promoter:-607C>A (rs1946518), -1297T>C (rs360719) (human) DNA:SNP:promoter:-137G>C (rs187238) (human) |
RGD |
PMID:20331879 |
RGD:8655865 |
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
|
RGD |
PMID:22147555 |
RGD:6892962 |
NCBI chrNW_004936501:11,100,170...11,112,112
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
mRNA,protein:increased expression:temporal artery,leukocytes, mononuclear |
RGD |
PMID:21220737 |
RGD:6482238 |
NCBI chrNW_004936485:8,857,688...8,894,270
|
|
G |
LOC101955076 |
low affinity immunoglobulin gamma Fc region receptor III-A |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16846526 |
RGD:5147974 |
NCBI chrNW_004937131:42,523...49,533
|
|
G |
Mfge8 |
milk fat globule EGF and factor V/VIII domain containing |
|
ISO |
|
RGD |
PMID:11748647 |
RGD:1582497 |
NCBI chrNW_004936483:14,868,171...14,880,552
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased activity:temporal artery |
RGD |
PMID:17502363 |
RGD:8657040 |
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
no_association |
ISO |
protein:increased expression:temporal artery (human) DNA:SNPs:promoter, CDS:rs17576, rs3918242, rs3918252 (human) protein:increased activity:temporal artery protein:increased expression:serum DNA:SNP:CDS:rs2250889 (human) |
RGD |
PMID:8843867 PMID:15998676 PMID:17502363 PMID:18512818 |
RGD:1580575 RGD:8547826 RGD:8547902 RGD:8657040 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Ptpn22 |
protein tyrosine phosphatase non-receptor type 22 |
no_association |
ISO |
DNA:polymorphism: :p.R620W (rs2476601) (human) DNA:polymorphism: :1858C>T (human) |
RGD |
PMID:16078327 PMID:23946333 |
RGD:7829739 RGD:7829744 |
NCBI chrNW_004936690:2,180,804...2,232,869
|
|
G |
Tlr4 |
toll like receptor 4 |
susceptibility no_association |
ISO |
DNA:polymorphism: :896A>G(rs4986790)(human) DNA:polymorphism: :896A>G,1196C>T(human) |
RGD |
PMID:19531762 PMID:21586524 |
RGD:7777158 RGD:7777159 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
|
RGD |
PMID:21771203 PMID:23999580 |
RGD:5148008 RGD:8696028 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:serum, cerebral spinal fluid: |
RGD |
PMID:20128675 |
RGD:7829722 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Vps37a |
VPS37A subunit of ESCRT-I |
|
ISO |
ClinVar Annotator: match by term: Idiopathic transverse myelitis |
ClinVar |
PMID:28492532 PMID:29473047 |
|
NCBI chrNW_004936573:6,306,218...6,343,544
|
|